Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Akums Drugs & Pharmaceuticals has received European GMP certificates for its two facilities, Plant 1 and Plant 2, both located at Haridwar, Uttarakhand. While the certification for Plant 1 represents a renewal of its existing EU-GMP approval, Plant 2 has received EU-GMP certification for the first time. Powered by Capital Market - Live News

Net profit of Akums Drugs & Pharmaceuticals declined 37.46% to Rs 40.78 crore in the quarter ended September 2025 as against Rs 65.21 crore during the previous quarter ended September 2024. Sales declined 1.51% to Rs 1017.53 crore in the quarter ended September 2025 as against Rs 1033.09 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1017.531033.09 -2 OPM %9.2811.73 - PBDT103.54122.75 -16 PBT65.6787.89 -25 NP40.7865.21 -37 Powered by Capital Market - Live News

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Net profit of Akums Drugs & Pharmaceuticals rose 5.50% to Rs 63.48 crore in the quarter ended June 2025 as against Rs 60.17 crore during the previous quarter ended June 2024. Sales rose 0.48% to Rs 1024.03 crore in the quarter ended June 2025 as against Rs 1019.11 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1024.031019.11 0 OPM %12.5912.56 - PBDT132.57121.54 9 PBT95.6587.48 9 NP63.4860.17 6 Powered by Capital Market - Live News